Paola Mantuano

Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity

Letizia Porcelli, Anna Elisa Quatrale, Paola Mantuano et al. · Molecular Oncology · 2012 · 58 citations · Full text

Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin‐deficient <i>mdx</i> mice: proof‐of‐concept study and independent validation of efficacy

Roberta Francesca Capogrosso, Paola Mantuano, Kitipong Uaesoontrachoon et al. · The FASEB Journal · 2017 · 57 citations · Full text

Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points

Roberta Francesca Capogrosso, Paola Mantuano, Anna Cozzoli et al. · Journal of Applied Physiology · 2017 · 51 citations · Full text

A long-term treatment with taurine prevents cardiac dysfunction in mdx mice

Antonietta Mele, Paola Mantuano, Michela De Bellis et al. · Translational research · 2018 · 49 citations · Full text

Cardiac Muscle, Cardiomyopathy, Heart Failure +9

Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy

Paola Mantuano, Francesca Sanarica, Elena Conte et al. · Biochemical Pharmacology · 2018 · 44 citations · Full text

Neurodegenerative Diseases, Duchenne Muscular Dystrophy, Medicine +6